Difference between revisions of "Sudden unexpected death in epilepsy: Identifying risk and preventing mortality"

From SUDEP Wiki
Jump to navigation Jump to search
(Created page with "''Lhatoo S, Noebels J, Whittemore V (2015). Sudden unexpected death in epilepsy: Identifying risk and preventing mortality. Epilepsia. 2015 Nov;56(11):1700-6.'' '''[https://w...")
 
 
Line 1: Line 1:
−
''Lhatoo S, Noebels J, Whittemore V (2015). Sudden unexpected death in epilepsy: Identifying risk and preventing mortality. Epilepsia. 2015 Nov;56(11):1700-6.''
+
{{Reference
  
−
'''[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852129/pdf/nihms780039.pdf Link to Article]'''
+
|reference=
  
−
'''Abstract:''' Premature death among individuals with epilepsy is higher than in the general population, and sudden unexpected death is the most common cause of this mortality. A new multisite collaborative research consortium, the Center for sudden unexpected death in epilepsy (SUDEP) Research (CSR), has received major funding from the National Institutes of Health (NIH) to examine the possible biologic mechanisms underlying this potentially preventable comorbidity and develop predictive biomarkers for interventions that could lower SUDEP incidence. This inaugural report describes the structure of the CSR, its priorities for human and experimental research, and the strategic collaborations and advanced tools under development to reduce this catastrophic outcome of epilepsy. The CSR Partners Program will work closely with committed volunteer agencies, industry, and academic institutions to accelerate and communicate these advances to the professional and lay community.
+
Lhatoo S, Noebels J, Whittemore V (2015). Sudden unexpected death in epilepsy: Identifying risk and preventing mortality. Epilepsia. 2015 Nov;56(11):1700-6.
  
−
'''Keywords:''' Autonomic dysfunction; Cardiorespiratory; Genetics; Imaging; Induced pluripotent stem cell; Neuropathology
+
|url=
  
−
==Context==
+
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852129/pdf/nihms780039.pdf
  
−
==Comments==
+
|abstract=
 +
 
 +
Premature death among individuals with epilepsy is higher than in the general population, and sudden unexpected death is the most common cause of this mortality. A new multisite collaborative research consortium, the Center for sudden unexpected death in epilepsy (SUDEP) Research (CSR), has received major funding from the National Institutes of Health (NIH) to examine the possible biologic mechanisms underlying this potentially preventable comorbidity and develop predictive biomarkers for interventions that could lower SUDEP incidence. This inaugural report describes the structure of the CSR, its priorities for human and experimental research, and the strategic collaborations and advanced tools under development to reduce this catastrophic outcome of epilepsy. The CSR Partners Program will work closely with committed volunteer agencies, industry, and academic institutions to accelerate and communicate these advances to the professional and lay community.
 +
 
 +
|keywords=
 +
 
 +
Autonomic dysfunction; Cardiorespiratory; Genetics; Imaging; Induced pluripotent stem cell; Neuropathology
 +
 
 +
|context=
 +
 
 +
 
 +
|comments=
 +
 
 +
 
 +
}}

Latest revision as of 14:02, 17 June 2019


Lhatoo S, Noebels J, Whittemore V (2015). Sudden unexpected death in epilepsy: Identifying risk and preventing mortality. Epilepsia. 2015 Nov;56(11):1700-6.

Link to Article

Abstract: Premature death among individuals with epilepsy is higher than in the general population, and sudden unexpected death is the most common cause of this mortality. A new multisite collaborative research consortium, the Center for sudden unexpected death in epilepsy (SUDEP) Research (CSR), has received major funding from the National Institutes of Health (NIH) to examine the possible biologic mechanisms underlying this potentially preventable comorbidity and develop predictive biomarkers for interventions that could lower SUDEP incidence. This inaugural report describes the structure of the CSR, its priorities for human and experimental research, and the strategic collaborations and advanced tools under development to reduce this catastrophic outcome of epilepsy. The CSR Partners Program will work closely with committed volunteer agencies, industry, and academic institutions to accelerate and communicate these advances to the professional and lay community.

Keywords: Autonomic dysfunction; Cardiorespiratory; Genetics; Imaging; Induced pluripotent stem cell; Neuropathology

Context

Comments

Network Graph

Retrieving data for the network graph...
Retrieved from "https://sudepwiki.pathology.jhmi.edu/index.php?title=Sudden_unexpected_death_in_epilepsy:_Identifying_risk_and_preventing_mortality&oldid=1703"